Clinical Trial Update: Genes Polymorphisms and Metabolic Effects of the Second Generation Antipsychotic Drugs in Patients With Schizophrenia

View source ↗

Summary

A clinical trial update examining genetic polymorphisms and metabolic effects of second generation antipsychotics in people with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Second generation antipsychotics

Snippet

Sponsor: Xijing Hospital | Conditions: Schizophrenia | Status: UNKNOWN